P108 Comparison of quality of life (QOL) between adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) and oral uracil/tegafur in high-risk, node-negative breast cancer – A phase III randomized trial (N-SAS BC 01)

✍ Scribed by H. Makino; K. Shimozuma; T. Watanabe; Y. Ohashi; N. Katsumata; H. Sonoo; S. Takashima

• Book ID: 114316021
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 45 KB
• Volume: 16
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(07)70168-6